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Cyclin-dependent kinase inhibitors (CKls) are crucial 
regulators of cell-cycle progression. The CKI Sic1 
controls the timing of DNA replication by inhibiting 
Clb-CdQ8 kinase. Phosphorylation of Sic1 by 
Cln-Cdc28 kinase alleviates this Inhibition by targeting 
Sic1 for degradation through the ubiquitin-mediated 
proteolytic pathway. 
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Cell proliferation requires duplication of alk cellular com- 
ponents, followed by their segregation into identical 
daughter cells. The mechanisms controlling this process 
are described by the cell-cycle paradigm, in which the 
twa major events of proliferation - DNA replication and 
chromosome segregatinn/cytokinesis (cellular division) - 
are temporally ordered by gap phases that separate them 
[I]. Because loss of cell-cycle contrgl, leading to unregu- 
lated proliferation, is a hallmark of tumorigenesis, much 
work in the last 20 years has focused on identifying the 
molecular components sirat facilitate or inhibit ce!l-cycle 
transitions. 
The ultimate targets of proliferative signals are the cyclin- 
dependent kinases (CDKQ, which catalyze positive transi- 
tions through the ccl1 cycle by transferring the gamma 
phosphate from ATP to protein substrates [I]. The sim- 
plicity of this reaction is in contrast to the complexity of 
the regulatory systems through which it is controlled. As 
the name implies, CDKs are positively activated by their 
association with a member of the cyciin family of proteins, 
and by other posttranslational modifications, The tempo- 
ral order of cell-cycle progression is maintained in part by 
the sequential expression and activation of specific cyclin- 
CDK complexes at each transitional period. 
Recent attention has focused on a novel mechanism for 
negatively regulating cell-cycle transitions by inhibiting 
the activity of these CDKs [Z]. The CDK inhibitors, or 
CKIs, are ubiquitous proteins found in cells from diverse 
species (from yeast to humans); they function by directly 
binding to and inactivating the cyclin-CDK complex 
(Fig. 1). Given the variety of cyclin-CDK complexes, it is 
not surprising that different classes of CKIs are used to 
regulate their activity, They are thought to have critical 
roles in such diverse processes as withdrawal from the 
cell cycle, maintenance of cell-cycle timing, checkpoint 
controls (mechanisms preventing inappropriate cell-cycle 
progression during processes such as DNA replication or 
repair), and differentiation [Z]. 
The cell uses three basic mechanisms to establish and 
maintain the exquisitely complex interactions amongst the 
proteins comprising the cell-cycle machinery: modulation 
of protein synthesis rates, biological activit;i, or half life. 
Although the control of protein expression and activity has 
long been recognized as integral to control of cell-cycle 
progression, the significance of selective proteolysis has 
only recently been elevated to equal status. The ubiqui- 
tin-mediated degradation of proteins provides the target- 
ing specificity and irreversibility necessary in a temporally 
ordered regulatory system such as the cell cycle. Here, 
we summarize the emerging evidence indicating a critical 
role for ubiquitin-mediaced proceolysis of CKIs in cell- 
cycle regulation. 
Sic1 degradation is required for S-phase entry in yeast 
The clearest example of ubiquitin-mediated destruction of 
a CKI comes from the yeast &c&~~~nyces cerevis&ze. The 
fact that these yeast double every 90 minutes under optimal 
conditions, combined with the ease of genetic analysis, 
makes them an attractive organism in which to study the 
ccl1 cycle. The CDK homolog in yeast is Cdc28, which is 
positively activated by association with the Ctn or Clb 
family of cyclins. 
The sequence of events required for progression from Gl 
through S phase is depicted in Figure 2. Midway through 
Gl, the cell kvaluates its capacity to complete replication 
of chromosomal DNA and cellular division. A commitment 
to proliferation, called Start, is dependent upon activation 
of the cyclin-dependent kinasc Cd& by association with 
the CIn (Gl type) cyclins [3]. Progression through Start 
simultaneously initiates parallel pathways culminating in 
DNA replication, duplication of the spindle pole body (the 
yeast microtubule-organizing center), and bud emergence. 
Cln3-Cd& launches this program by activating transcrip- 
tion of Clns 1 and 2 and Clbs 5 and 6 in GI [4]. Although. 
both Clns arid Clbs associate with Cdc28 after synthesis, 
only the Cln-Cdc28 complexes are immediately activated. 
The Clb-Cd& complexes are maintained in an inactive 
state through association with Sick, whereas Cln-Cd&3 
kinase activity is unaffected by this inhibitor [S]. 
Deletion of the genes for Clns l-3 causes cell-cycle arrest 
in GI without bud emergence, spindle-pole duplication, 
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or DNA replication [6]. In contrast, overexprcssion of 
Clns 1-3 results in Gl acceleration, indicating that they are 
rate limiting for progression through Start [7]. Clns 1 and 2 
are not sufficient for initiating DNA replication on sched- 
ule, however, as deletion of Clbs 5 and 6 delays S-phase 
entry by 30 minutes 181. Nevertheless, bud emergence and 
spindle-pole duplication are still initiated on time, indicat- 
ing chat Clb5 and 6 are dispensable for these mitocic 
events. The dependence of S-phase entry on Clb5 and 
6-Cd&8 kinase activity requires that Sic1 be inactivated. 
Thus, Sic1 coordinates the timing of S-phase initiation 
with other cell-cycle events by preventing the pre-macure 
activation of the Clb5 and 6-Cd&?8 kinases [9]. 
It has been known for some time from genetic experi- 
ments that exit from Gl into S phase also requires the 
gene products of CDC3$ CDM, and CfiCs3 [lOj. Mutants 
in CDC3B duplicate spindle-pole bodies and bud repeat- 
edly, but fail to enter S phase, similar to the c&5 and c$M 
Figure 2 
double-deletion mutants [9]. Despite high levels of the 
Gl Cln-Cd& kinase activity in these cells, the cells fail 
to progress through Cl. The failure to enter S phase is a 
consequence of the dearth of Clb5 and 6-C&228 kinase 
activity in the c~z’c34 mutants, coincident wirh an accumu- 
lation of Sicl. The discovery that CBC.34 encodes an E2 
enzyme of the ubiquitin conjugating system immediately 
suggested a mechanism in which degradation of Sic1 
restores the Clb-CdcZS kinase activity required for initiat- 
ing DNA replication 191. 
Targeting Sic1 for degradation 
Cdc34 substrates share two features: they are phosphory- 
lated, and they contain internal PEST sequences (i.c., 
proline, glutamic acid, serine, and threonine) [ 11 J. Phos- 
phorylatiun is a common means of marking a protein for 
ubiquitination, and probably facilitates recognition by 
ubiquitin-conjugating enzymes. Although the exact func- 
tion of the PEST sequence is unclear, it is a common 
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GI/S-phase progression in yeast. 
Cln3-Cdc28 kinase activity in Gl phase 
activates transcription of the genes encoding 
Clnsl and 2 and Clbs 5 and 6. While 
Cln-Cdc28 complexes are immediately 
activated, Clb-CdcZE kinase activity is 
inhibited by Sick. Cln-Cdc28 
phosphotylates Ski, leading to its 
degradation and subsequent activation of 
Clb-CdcZB kinase, which is required for 
entry into S phase. 
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motif found in unstable proteins and is required for refractory to Sic1 inhibition. In fact, Sic1 is a substrate for 
maximal rates of degradation. It may direct ubiquicination Cln-Cdc28 [lZ]. Sic1 contains a PEST sequence, is highly 
at another site in the protein, facilitate Cdc34 recognition, phosphorylated in the cell, and its phosphorylation state 
of perhaps prevent de-ubiqutination. correlates with the appearance of Cln-Cdc28 kinase activ- 
ity LIZ]. Cln-Cdc28 phosphorylares Sicf, targeting it for 
Although purified Sic1 speciftcally inhibits Clh-Cdc28 degradation through the ubiquicin pathway and alleviating 
kinase activity by direct interaction, Cln-Cd& kinases are Clb-Cdc28 inhibition (Fig. 2). 
Figure 3 -~____ 
The ubiquitin-mediated proteolytic pathway. 
(a) The enzymatic reactions of the ubiquitin 
pathway. Covalent bonds are depicted by 
dashes, noncovalent binding by squares. 
Action of the Et 1 E2 and E3 enzymes results 
in attachment of multiple ubiquitin groups to 
fysine residues in the target protein. 
(b) The substrate targeted for degradation is 
anchored to the proteasome by its ubiquitin 
chain. The substrate is then simultaneously 
unwound and threaded into the catalytic 
center of the proteasome for proteolytic 
degradation. CC) Schematic representation of 
the 26s ptoteasome (left) and cross section 
(tight) of the central 205 portion of the 
particle, The 205 proteasome is composed 
of two central P-subunit rings, with two outer 
a-subunit rings, each with seven members, 
The space between the a-subunit and 
p-subunit rings defines the small outer 
chambers, while the space between the two 
B-subunit rings defines the large central 
chamber. Proteolysis takes place within the 
farge central chamber. The target protein 
must enter the chamber through a 13 8, pore 
in the center of the a-subunit ring. 
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Genetic experiments lend support to this model. Deletion 
of the gene encoding Sicl, while not lethal, results in pre- 
mature DNA replication and genetic instability (broken or 
lost chromosomes) 1131. Furthermore, deleting Sic1 sup- 
presses the phenotype of the &34 mutation, indicating 
that Sic1 is the only essential target of this enzyme chat 
must be degraded to transverse the Gl/S phase boundary 
191. It should be noted that the ~u’c34/52’ccl double mutant 
still experiences growth slowdown, since Cdc34 targets 
other substrates for degradation. Finally, the sicl deletion 
rescues the cln triple deletion, suggesting that phosphory- 
lation of Sic1 is an essential function of Cfn-Cd& kinases 
[l&14]. There are obviously other important Cln sub- 
strates, however; although the &1/&z mutant cells progress 
through Gl and enter S phase, they are very sick. 
Mechanism of ubiquitin-mediated degradation 
The first event in targeting a protein for destruction is 
the conjugation of ubiquitin tco the target protein by a 
cascade of enzymatic reactions (Fig. 3a) tl.51. Ubiquitin is 
an abundant 76 amino acid protein, which is highly con- 
served from yeast to humans. l’he ubiquicin-activating 
enzyme El first binds to ubiquitin and ATP; magnesium- 
dependent hydrolysis of A1’P at the a-phosphate results 
in the formation of ubiquitin adenylate (Ub-AMP) tightly 
bound to El. The ubiquitin adenylate intermediate acts as 
a donor of ubiqttitin to an active-site slltfhydryl group of 
El in a magnesium-independent f&ion through a high- 
energy thioester bond. Interestingly, the El-ubiquitin 
thiocster undergoes another round of magnesium-depen- 
dent Ub-AMP formation, resulting in the ternary complex 
of E l-ubiquitin noncovatently bound to Ub-AMP 
The activated ubiquitin in the ternary complex is tran- 
fered by transacylation to a thiol group of the E2 family of 
tibiquicin-car&r proteins. EZ-ubiquitin thiol esters can 
donate the ubiyuitin directly to the substrate by isopep- 
tide bond formation with the E amino groups of substrate 
lysine residues. Alternatively, transfer of ubiquitin from 
EZ may be assisted by an E3 family member protein, 
which functions as a ubiquicin ligase (Fig. 3a). Additional 
ubiquities arc added to the first by the same mechanisms, 
ftirming one or more chains of ubiquitin, which are 
thought to serve as signals for transportation to the protea- 
some. Most cells have only a single El, whereas there are 
at least 12 genes encoding E2 enzymes in yeast [1.5]. 
Thus, the targeting specificity associated with the ubiqui- 
tin pathway arises through the EZ and F3 enzymes. 
Upon arrival at the 265 proteasomc, the ubiquitin chains of 
the substrate are used for docking (Fig. 3b) [16]. The sub- 
strate is then unfolded in an ATP-dependent manner, fol- 
lowed by cleavage and recycling of the ubiquirin chain. 
The central, ZOS portion of the protcasome is.a multiple 
subunit, barrel-shaped particle, with four stacked rings of 7 
polypeptides each (Fig. 3~). The crystal structure shows 
a central channel with three chambers - two small 13 A 
openings at the ends of the barrel, and a larger chamber in 
the middle composed of p subunits [17]. The narrow open- 
ings are only wide enough to permit passage of unfolded 
proteins to the two proteolytic active sites sequestered in 
the middle chamber, ensuring that only ubiquitinated 
proteins are degraded. 
A unique mechanism of catalysis WCS the hydroxyl group 
of the atnino-terminal rhreonjne of the p subunit as the 
nuclcophile. The crystal structure of the proteasome in a 
complex with an inhibitor suggests that the transition state 
is similar co that of the serine proteases, although the 
familiar catalytic triad is lacking. The IY amino group of rhe 
amino-terminal threonine is thought to serve as the basic 
amino acid, which accepts the proton from the threonine 
hydruxyl in the transition state. Spatial orientation of the 
two active sites is such that they are spanned by a polypep- 
tide chain of 7-8 amino acids, the,fragment size generated 
by proteolysis [ 171. 
Proteolytic control of the G1/S phase transition - a twice 
told tale? 
Although our understanding of CKI regulation by prote- 
olytic degradation is still limited, the available evidence 
provides important insights into the control of cell-cycle 
progression. In yeast, the Clnl and Z-Cdc28 kinase phos- 
phorylates Sicl, targeting it for degradation. The depen- 
dence of Clh-Cd&+ activation on Cln-Cd&t3 activity 
nicely illustrates the temporal nature of cell-cycle progres- 
sion achieved through a system of checks and balances. 
Ir should be pointed our, however, that involvement of the 
ubiquitin-mediated pathway in Sic1 regulation has nor yet 
been directly demonstrated. Changes in the Sic1 half-life at 
S phase have not been determined, and ubiquitinated Sic1 
intermediates have not been observed. Even less is known 
about proteolytic regulation of CKIs in mammalian cells, 
althuugh ubiquitinated intermediates have been isolated 
1181. Nevertheless, the realization that CKIs, at least in 
yeast, are both inhibitors and substrates of cyclin-CDK 
complexes is particularly intriguing. This duality has cur- 
rently at-tracted little attention from researchers in the 
mammalian cell-cycle field, but if past examples frum yeast 
are any indication, it should be seriously considered. 
Acknowledgements 
RJS is supported by the Cancer Research Fund of the Damon 
Runyon-Walter Winchell Foundation fellowship DRG-I 313. 
References -._..--- 
Pines, J. (1995). Cyclins and cyclin-dependent kmases: a biochemical 
review. Biochem. J. 308,697-711. 
Sherr, C.J. & Roberts, 1.M. (1995). inhibitors of mammalian Gi cycfin- 
dependent kinases. Genes Dev. 9,1149-i 163. 
Hartwell, LA. (1974). Saccharomyces cerevisiae cell cycle. Bacterial. 
Rev. 38, 164-198. 
Tyers, M., Tokiwa, G. & F&her, B. (1993). Comparfson of the S. 
cerevisiae Gl cyciins: Cln3 may be an upstream activator of Glnl, 















Gln2, and other cyclins. EiWBO J. 12, 1955-l 968. 
Mendenhall, M.D. (1993). An inhibitor of p34opcz* protein kinase 
activity from Sacchharomyces cerevisiae. Science 259. 216-219. 
Richardson, HE., Wittenberg, C., Cross, F. & Reed, S.I. (1989). An 
essential GZ function for cyclin-like proteins in yeast. Gel/ 59. 
1127-1133. 
Crass, FR. (1988). DAFl, a mutant gene affectjng size control, 
pheromone arrest, and ceil cycle kinetics of Saccharomyces 
cerevisiae. Mol. Cell. Bid. 8, 4675-4684. 
Schwab, E. & Nasmyth. K. ($993). CLE5 and CLBS, a new pair of 
t3 cyclins involved in S phase and mitotic spindle formation in 
S. cerevisiae. Genes Dev. 7, 1160-l 175. 
Schwab, E., Bohm, T., Mendenhall, M.U. % Nasmyth, K. (1994). The 
Btype cyclin kinase inhibitor p40srci controls the G1 to S phase 
transition in S. cerevisiae. Cell 79, 233-244. 
Goebl, M.G., Yochem, J.. Jentsch, S., McGrath. J.P., Varshavsky, A. 
% Byers, 6. (1988). The yeast cell cycle gene COG34 encodes a 
ubiquitin-conjugating enzyme. Science 241, 1331-l 335. 
Rogers, S., Welfs, R. & Rechsteiner, M. (1986). Amino acid 
sequences common to rapidly degraded proteins: the PEST 
hypothesis. Science 234, 364-368. 
Schneider, E.L., Yang, Q.H. & Futcher, A.B. (1996). Linkage of 
replication to Start by the Cdk inhibitor Sicl. Science 272. 560-662. 
Nugroho, T.T. & Mendenhall, M.D. (1994). An inhibitor of yeast cyclin- 
dependent protein kinase plavs an important role in ensurina the 
genomic integrity of daughte;cells. co/. Cell. &I. 14, 3325-3328. 
Tyers, M. (1996). The cyclin-dependent kinase inhibifor p40Sic1 
imposes the requirement for CIn QI function at start. F&c. Nat/. 
Acad. SC;. USA 93,7772-7776. 
Hershko, A. & Ciechanover;A. (1992). The ubiauitin.svstem for protein 
degradation. Annu. Rev. Bic~chkm. 61, 761-807. ’ ’ 
Cnux, O., Tanaka, K. & Goldberg. A.L. (1996). Structure and functions 
of the 20s and.26S proteasomes. Annu. Rev, Biochem. 65, 801-847. 
Lowe, J., Stock, O., Jap, B., Zwickl, P, Baumeister, W. & Huber, R. 
(1995) Crystal structure of the 20s proteasome from the Archaeon 7; 
acidophilum at 3.4 A resolution. Science 269, 533-539. 
Pagano, et a/., & Rolfe, M. (1995). Role of the ubiquitin-proteasome 
pathway in regulating abundance of the cyclin-dependent kinase 
inhibitor ~27. Science 269, 682-685. 
